Peripheral neuropathy in HIV

International Journal of STD and AIDS

Volumn 8, Issue 1, 1997, Pages 16-22

  Sadler, M ^a   Nelson, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cytomegalovirus; HIV infection; peripheral neuropathies; review; treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CORTICOSTEROID; DAPSONE; DIDANOSINE; ISONIAZID; METRONIDAZOLE; STAVUDINE; STREPTOMYCIN; THALIDOMIDE; VINCRISTINE; ZALCITABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CYTOMEGALOVIRUS INFECTIONS; EDUCATION, MEDICAL, CONTINUING; HIV INFECTIONS; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0031026863     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971918706     Document Type: Review

References (45)

1. Lange DJ, Britton CB, Younger DS, Hays AP. The neuromuscular manifestations of human immunodeficiency infections. Arch Neurol 1988;45:1084-8
2. Fuller GN, Jacobs JM, Guiloff R. Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg Psychiatr 1993;56:372-89
3. Piette AM, Tusseau F, Vignon D, et al. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet 1986;i:852
4. Vendrell J, Heredia C, Pujol M, Vidal J, Blesa R, Graus F. Guillain-Barré syndrome associated with seroconversion for anti-HTLVIII. Neurology 1987;37:544
5. Cornblath DR, McArthur JC, Kennedy PGE, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotrophic virus type III infection. Ann Neurol 1987;21:32-40
6. Thornton CA, Latif AS, Emmanuel JC. Guillain-Barré syndrome associated with human immunodeficiency virus in Zimbabwe. Neurology 1991;41:812-5
7. Dalakas MC, Pezeshkpour GH. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 1988;23(suppl):S38-S48
8. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following campylobacter enteritis. Neurology 1990;40:1900-2
9. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RPF. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatr 1988;51:613-8
10. Grafe MR, Wiley CA. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann Neurol 1989;25:561-6
11. Vinters HV, Kwok MK, Ho HW, et al. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 1989;112:245-68
12. Leger JM, Bouche P, Bolgert F, et al. The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatr 1989;52:1369-74
13. Cornblath DR, Chaudhry V, Griffin JW. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 1991;30:104-6
14. Goldstein JM, Azizi SA, Booss J, Vollmer TL. Human immunodeficiency virus-associated motor axonal polyradiculoneuropathy. Arch Neurol 1993;50:1316-9
15. McCombe PA, Wilson R, Prentice RL. Anti-ganglioside antibodies in peripheral neuropathy. Clin Exp Neuro 1992;29:182-8
16. Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr 1992;5(suppl):S33-S36
17. Gherardi R, Lebargy F, Gaulard P, Mhiri C, Bernaudin JF, Gray F. Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 1989;321:685-6
18. Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol 1988;23:461-5
19. Price RW, Worley JM. Neurological complications of HIV-1 infection and AIDS. In: Broder S, Merigan TC, Bolognesi D, eds. Textbook of AIDS Medicine. Baltimore: Williams and Wilkins, 1994; 489-505
20. Said G, Lacroix C, Chemouilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991;29:139-46
21. deGans J, Tiessens G, Portegies P, Tutuarima JA, Troost D. Predominance of polymorphonuclear leukocytes in cerebrospinal fluid of AIDS patients with cytomegalovirus polyradiculomyelitis. J Acquir Immune Defic Syndr 1990;3:1155-8
22. Snoek R, Gerard M, Sadzot-Delvaux C, et al. Meningoradiculoneuritis due to ganciclovir-resistant varicella zoster virus in an acquired deficiency syndrome patient. J Med Virol 1994;42:338-47
23. Rizzuto N, Cavallaro T, Monaco S, et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol 1995;90:244-50
24. So YT, Holtzman DM, Abrams DI, Olney RK. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based study. Arch Neurol 1988;45:945-8
25. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-85
26. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr 1995;9: 379-88
27. Barohn RJ, Gronseth GS, Amato AA, et al. Cerebrospinal fluid and nerve conduction abnormalities in HIV-positive individuals. J Neurol Sci 1996;136:81-5
28. Fuller GN, Jacobs JM, Guiloff RJ. Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection. Lancet 1989;ii:937-8
29. Fuller GN, Jacobs JM, Guiloff RJ. Subclinical peripheral nerve involvement in AIDS: an electrophysiological and pathological study. J Neurol Neurosurg Psychiatr 1991;54:318-24
30. Tyor WR, Glass JD, Griffin JW. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349-60
31. Mahieux F, Gray F, Fenelon G, et al. Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS. J Neurol Neurosurg Psychiatr 1988;52:270-4
32. Beydoun SR. Misdiagnosis of cytomegalovirus polyradiculopathy, coexisting with HIV neuropathy. Muscle Nerve 1991;14:575-6
33. Jacobson MA, Mills J, Rush J, et al. Failure of antiviral therapy for acquired deficiency syndrome-related cytomegalovirus myelitis. Arch Neurol 1988;45:1090-2
34. So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994;35:53-8
35. deGans J, Portegies P, Tiessens G, Troost D, Danner SA, Lange JMA. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS 1990;4:421-5
36. Lanska DJ, Lanska MJ. Treatable causes of meningomyeloradiculitis in individuals infected with human immunodeficiency virus. Arch Neurol 1989;46:722-3
37. Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1995;172:527-31
38. Blysma SS, Achim CL, Wiley CA, et al. The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Arch Ophthalmol 1995;113:89-95
39. Graveleau PH, Perol R, Chapman A. Regression of cauda equina syndrome in AIDS patients being treated with ganciclovir. Lancet 1989;ii:511-2
40. Manji H, Malin A, Connolly S. CMV polyradiculopathy in AIDS - suggestions for new strategies in treatment. Genitourin Med 1992;68:192-8
41. Fuller GN, Gill SK, Guiloff RJ, et al. Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet 1990;335:48-9
42. Cinque P, Baldanti F, Vago L, et al. Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV detection in cerebrospinal fluid. J Infect Dis 1995;171:1603-6
43. Smith IL, Shinkai M, Freeman WR, Spector SA. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterisation of sequential virus isolates. J Infect Dis 1996;173:1481-4
44. De Clerq E. Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact. Adv Virus Res 1992;42:1-55
45. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS Hum Retrovir 1995;9:153-61